DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Retinoblastoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/txd6g5/absence) has announced the addition of the "Absence Seizure-Global ...
17d
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
The "Active Pharmaceutical Ingredients (API) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Active Pharmaceutical Ingredients (API) is ...
It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results